2010
DOI: 10.1016/j.jdermsci.2010.03.018
|View full text |Cite
|
Sign up to set email alerts
|

Serum IL-22 correlates with psoriatic severity and serum IL-6 correlates with susceptibility to phototherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
48
0
2

Year Published

2011
2011
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 75 publications
(58 citation statements)
references
References 10 publications
7
48
0
2
Order By: Relevance
“…Increased serum IL-22 production also has been found in several autoimmune diseases such as psoriasis and CD [14,18]. However, in patients with SLE, decreased serum and plasma IL-22 production were showed by our groups and Cheng et al, respectively [19,20].…”
Section: Discussionmentioning
confidence: 46%
“…Increased serum IL-22 production also has been found in several autoimmune diseases such as psoriasis and CD [14,18]. However, in patients with SLE, decreased serum and plasma IL-22 production were showed by our groups and Cheng et al, respectively [19,20].…”
Section: Discussionmentioning
confidence: 46%
“…Increased levels of Th17 cells and their associated cytokines including IL-23, IL-17, and IL-22 have been found in human psoriatic skin (6,11,12). Elevated IL-22 concentrations were measured in plasma from patients and IL-22 production correlated positively with severity of the disease and negatively with response to therapy suggesting a significant role of this cytokine in psoriasis (5,7,13). T lymphocytes appeared to represent a major source of IL-22 in skin lesions (7) and treatment with cyclosporine A downregulated both IL-17 and IL-22 expression in those patients (14).…”
mentioning
confidence: 99%
“…IL-6 and IL-8 both were found to be positive in our skin tissue and it accords with previously known data as these interleukins have been found in high levels in active psoriasis patients, both skin and serum samples. The serum level of IL-6 has also been described as a good predictor for the successful topical therapy outcome as it prevents from immunosupression [2,4,9].…”
Section: Discussionmentioning
confidence: 99%